Thieno[2,3-c]pyrazole derivatives of formula (I) and pharmaceuticallyacceptable salts thereof, as defined in the specification, process for theirpreparation and pharmaceutical compositions comrising them are disclosed; thecompounds of the invention may be useful in therapy, in the treatment ofdiseases associated with a disregulated protein kinase activity, like cancer.